Graeme McFarland
Vascular Surgery · Birmingham, ALNPI 1144510959
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,606 of the $9,631 with a category attached, or 79.0%. It is spread thinly across 36 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations.
Across 165 payments — averaging $58.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$2K
- Endologix LLC$2K
- Silk Road Medical, Inc.$1K
- Stryker$1K
- Medtronic$602
- Boston Scientific$391
- plus $2K from 30 others
What the payments were for
- Grants$621%
- Travel & lodging$1,96320%
- Food & beverage$7,60679%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 31 | $2,054 |
| Endologix LLC | 11 | $1,599 |
| Silk Road Medical, Inc. | 20 | $1,363 |
| Stryker | 10 | $1,265 |
| Medtronic | 13 | $602 |
| Boston Scientific | 6 | $391 |
| Kerecis Limited | 4 | $256 |
| Imperative Care, Inc | 3 | $226 |
| Cook Medical LLC | 8 | $213 |
| Polynovo North America LLC | 11 | $181 |
| Penumbra, Inc. | 1 | $147 |
| Bard Peripheral Vascular, Inc. | 5 | $147 |
| Bolton Medical Inc | 1 | $145 |
| Lemaitre Vascular, Inc. | 8 | $126 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $84 |
| Baxter Healthcare | 4 | $80 |
| Philips North America LLC | 1 | $72 |
| Smith+Nephew | 4 | $66 |
| Cagent Vascular Inc | 2 | $61 |
| Urgo Medical North America, LLC | 2 | $59 |
| Mimedx Group, Inc. | 2 | $58 |
| Ossur Americas, Inc. | 1 | $44 |
| Mozarc Medical US LLC | 2 | $43 |
| CSL Behring | 1 | $37 |
| Intuitive Surgical | 1 | $35 |
| Johnson & Johnson | 1 | $34 |
| Artivion, Inc. | 1 | $31 |
| Tactile Systems Technology Inc | 2 | $30 |
| Teleflex LLC | 1 | $29 |
| Inspiremd Ltd | 1 | $26 |
| Terumo Medical Corporation | 1 | $24 |
| Organogenesis Inc. | 1 | $23 |
| Inari Medical, Inc. | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Conmed Corporation | 1 | $22 |
| Angiodynamics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$823
- GORE VIABAHN VBX Balloon Expandable Endo$811
- Torus Stent Graft System$754
- ENDOCROSS Device$754
- ENROUTE Transcarotid Stent System$673
- ENHANCE Transcarotid Peripheral Access Kit$673
- ENROUTE 0.014 Guidewire$673
- ANCHOR L$672
- AERO$672
- Alto Abdominal Stent Graft System$619
- TRITANIUM$204
- ENROUTE Transcarotid Stent$151
- CHESAPEAKE$150
- Indigo System$147
- Relay Plus$145
- Ranger$130
- GORE TAG Thoracic Endoprosthesis$125
- GORE EXCLUDER AAA Endoprosthesis$114
- ELUVIA$112
- Heli-FX EndoAnchor System$110
How this compares
$9,631 in reported general payments places this provider in the 65th percentile of 61 vascular surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 47 | $37,472 |
| EliquisApixaban | 43 | $27,951 |
| Pregabalin | 22 | $2,330 |
| ClopidogrelClopidogrel Bisulfate | 96 | $1,249 |
| Cilostazol | 39 | $1,197 |
| Gabapentin | 82 | $978 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 93 | $736 |
| Atorvastatin Calcium | 24 | $242 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $34 | $37,47247 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 61 vascular surgery providers in Alabama.
Other vascular surgery in Birmingham
- Albert PacificoBirmingham$5.1M
- Benjamin PearceBirmingham$37K
- William HolmanBirmingham$25K
- Stephen HeinzmanBirmingham$18K
- Jarrad RowseBirmingham$10K
- Vernon HorstBirmingham$9K
- James KirklinBirmingham$6K
- Danielle SutzkoBirmingham$5K
- Mark PattersonBirmingham$5K
- Michael GleasonBirmingham$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.